• Reference Citation Analysis
  • v
  • v
  • Find an Article
  • Find an Author
Download
Number Citation Analysis
1
Lanthier L, Grbic D, Plourde MÉ, Cauchon M. [Among patients with metabolic dysfunction associated steatohepatitis (MASH), is resmetirom 80 or 100mg superior to placebo in reversing MASH and/or fibrosis on liver biopsy, and is it safe?]. Rev Med Interne 2024:S0248-8663(24)00569-1. [PMID: 38755073 DOI: 10.1016/j.revmed.2024.05.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2024] [Accepted: 05/02/2024] [Indexed: 05/18/2024]
2
Lanthier L, Plourde MÉ, Cauchon M. [Among patients with mild ischemic stroke or high-risk TIA, does combined clopidogrel-aspirin therapy initiated within 72hours after stroke onset and given for 21 days reduce the recurrence of stroke at 90 days compared to aspirin alone, and is it safe?]. Rev Med Interne 2024;45:251-252. [PMID: 38388304 DOI: 10.1016/j.revmed.2024.02.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2024] [Accepted: 02/03/2024] [Indexed: 02/24/2024]
3
Lanthier L, Langlois MF, Plourde MÉ, Cauchon M. [Among adults with cardiovascular disease and BMI≥27kg/m2 but no diabetes, does semaglutide lower risk of cardiovascular mortality, myocardial infarction, or stroke when compared with placebo, and is it safe?]. Rev Med Interne 2024;45:178-179. [PMID: 38228454 DOI: 10.1016/j.revmed.2024.01.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2023] [Accepted: 01/01/2024] [Indexed: 01/18/2024]
4
Lanthier L, Mayette M, Plourde MÉ, Cauchon M. [In a patient undergoing mechanical ventilation for at least 3 days, does a 3-day course of inhaled amikacin reduce the incidence of ventilator-associated pneumonia compared to placebo, and is it safe?]. Rev Med Interne 2024;45:55-56. [PMID: 38142212 DOI: 10.1016/j.revmed.2023.12.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2023] [Accepted: 12/02/2023] [Indexed: 12/25/2023]
5
Lanthier L, Plourde ME, Cauchon M. [Does pitavastatine prevent atherosclerotic cardiovascular events in people living with HIV on antiretroviral therapy with low to moderate cardiovascular risk, and is it safe?]. Rev Med Interne 2023;44:579-580. [PMID: 37704460 DOI: 10.1016/j.revmed.2023.09.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2023] [Accepted: 09/04/2023] [Indexed: 09/15/2023]
6
Lanthier L, Mayette M, Plourde MÉ, Cauchon M. [In adults admitted to the intensive care unit for severe community-acquired pneumonia, does adding hydrocortisone to standard treatment reduce 28-days mortality compared to placebo, and is it safe?]. Rev Med Interne 2023;44:383-384. [PMID: 37183146 DOI: 10.1016/j.revmed.2023.04.442] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2023] [Accepted: 04/20/2023] [Indexed: 05/16/2023]
7
Lanthier L, Viau-Trudel A, Plourde ME, Cauchon M. [In patients with moderate chronic kidney disease, including non-diabetic patients, does empagliflozin provide renal and cardiovascular benefit compared to placebo, and is it safe?]. Rev Med Interne 2023:S0248-8663(23)00085-1. [PMID: 37045658 DOI: 10.1016/j.revmed.2023.03.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2023] [Accepted: 03/05/2023] [Indexed: 04/14/2023]
8
Lanthier L, Mutchmore A, Plourde MÉ, Cauchon M. [In patients with type 2 diabetes on metformin, the addition of which antihyperglycemic class among a sulfonylurea (glimepiride), a DPP-4 inhibitor (sitagliptin), a GLP-1 agonist (liraglutide), or basal insulin (glargine) is the most effective to achieve and maintain good glycemic control?]. Rev Med Interne 2023;44:48-49. [PMID: 36443201 DOI: 10.1016/j.revmed.2022.11.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2022] [Accepted: 11/07/2022] [Indexed: 11/26/2022]
9
Lanthier L, Plourde MÉ, Cauchon M. [In patients hospitalized for COVID-19, does baricitinib reduce 28-days mortality compared to standard treatment, and is it safe?]. Rev Med Interne 2022;43:634-635. [PMID: 36123199 PMCID: PMC9452413 DOI: 10.1016/j.revmed.2022.09.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2022] [Accepted: 09/05/2022] [Indexed: 12/15/2022]
10
Lanthier L, Plourde MÉ, Cauchon M. [In high-risk patients undergoing noncardiac surgery, does tranexamic acid result in a lower incidence of bleeding while being safe from a cardiovascular point of view compared to placebo?]. Rev Med Interne 2022;43:455-456. [PMID: 35725935 DOI: 10.1016/j.revmed.2022.05.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2022] [Accepted: 05/27/2022] [Indexed: 11/26/2022]
11
Lanthier L, Lauzon D, Plourde MÉ, Cauchon M. [In hypertensive patients aged 60 to 80 years, does more intensive antihypertensive treatment reduce cardiovascular events compared to standard treatment while being safe?]. Rev Med Interne 2022;43:128-129. [PMID: 35012789 DOI: 10.1016/j.revmed.2021.12.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2021] [Accepted: 12/23/2021] [Indexed: 11/19/2022]
12
Lanthier L, Mayette M, Plourde MÉ, Cauchon M. [In patients hospitalized for COVID-19 with hypoxia and systemic inflammation, does tocilizumab reduce 28-days mortality compared to standard treatment, and is it safe?]. Rev Med Interne 2021;42:517-518. [PMID: 34147258 PMCID: PMC8188384 DOI: 10.1016/j.revmed.2021.06.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2021] [Accepted: 06/06/2021] [Indexed: 12/15/2022]
13
Lanthier L, Langlois MF, Plourde MÉ, Cauchon M. [For obese patients or for patients who are overweight and have an associated comorbidity, how safe and effective is semaglutide as compared with placebo as an adjunct to lifestyle intervention for reducing body weight and other related end points?]. Rev Med Interne 2021;42:369-370. [PMID: 33838950 DOI: 10.1016/j.revmed.2021.03.334] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2021] [Accepted: 03/27/2021] [Indexed: 10/21/2022]
14
Lanthier L, Carignan A, Plourde MÉ, Cauchon M. [In subjects 16 years of age and older, is messenger RNA vaccine BNT162b2 against COVID-19 effective and safe?]. Rev Med Interne 2021;42:227-228. [PMID: 33612319 PMCID: PMC7874978 DOI: 10.1016/j.revmed.2021.02.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2021] [Accepted: 02/06/2021] [Indexed: 11/17/2022]
15
Lanthier L, Plourde MÉ, Cauchon M. [In patients with type 2 diabetes, chronic kidney disease and albuminuria, is finerenone, a selective minerocorticoid receptor antagonist, effective and safe for lowering CKD progression?]. Rev Med Interne 2021;42:144-145. [PMID: 33455835 DOI: 10.1016/j.revmed.2020.12.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2020] [Accepted: 12/28/2020] [Indexed: 11/18/2022]
16
Lanthier L, Masse M, Plourde MÉ, Cauchon M. [In patients with moderate chronic kidney disease with albuminuria, including non-diabetic patients, does dapagliflozin provide renal and cardiovascular benefit compared to placebo?]. Rev Med Interne 2020;42:65-66. [PMID: 33309055 DOI: 10.1016/j.revmed.2020.11.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2020] [Accepted: 11/08/2020] [Indexed: 11/17/2022]
17
Lanthier L, Dussault C, Huard G, Plourde ME, Cauchon M. Chez les patients avec maladie coronarienne athérosclérotique chronique stable, quelle est l’efficacité de la colchicine pour prévenir les événements cardiovasculaires et son innocuité comparativement au placebo ? Rev Med Interne 2020;41:862-863. [DOI: 10.1016/j.revmed.2020.10.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2020] [Accepted: 10/04/2020] [Indexed: 11/26/2022]
18
Lanthier L, Mayette M, Huard G, Plourde MÉ, Cauchon M. [In patients hospitalized for COVID-19, does dexamethasone reduce 28-days mortality compared to standard treatment?]. Rev Med Interne 2020;41:790-791. [PMID: 33077267 PMCID: PMC7546229 DOI: 10.1016/j.revmed.2020.08.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2020] [Accepted: 08/31/2020] [Indexed: 12/13/2022]
19
Lanthier L, Bouchard N, Huard G, Plourde ME, Cauchon M. Le dépistage du cancer du poumon chez les sujets à risque à l’aide de la tomodensitométrie axiale à faible dose est-il efficace en termes de diminution de la mortalité ? Rev Med Interne 2020;41:350-351. [DOI: 10.1016/j.revmed.2020.04.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2020] [Accepted: 04/02/2020] [Indexed: 12/24/2022]
20
Lanthier L, Plourde MÉ, Huard G, Cauchon M. [A tool for knowledge transfer in internal medicine from Quebec: "BaladoCritique: Journal Club" podcast]. Rev Med Interne 2019;40:410-411. [PMID: 30928245 DOI: 10.1016/j.revmed.2019.03.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2019] [Accepted: 03/12/2019] [Indexed: 11/15/2022]
21
Leduc Y, Cauchon M. Finding the right information at the right time. Part 2: MEDLINE, medical journals, and websites. Can Fam Physician 2001;47:567-9, 577-9. [PMID: 11281091 PMCID: PMC2018405] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
22
Cauchon M, Leduc Y. Finding the right information at the right time. Part 1: Drugs, reference books, clinical practice guidelines. Can Fam Physician 2001;47:337-8, 348-9. [PMID: 11228035 PMCID: PMC2016242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
23
Emond JG, Cauchon M, Ouellet J, Beaulieu MD, Brailovsky CA, Leduc Y. [Interobserver agreement on diagnoses classified according the International Classification of Primary Care]. Can Fam Physician 1998;44:2128-33. [PMID: 9805167 PMCID: PMC2277918] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/09/2023]
24
Leduc Y, Cauchon M, Emond JG, Ouellet J. [Utilization of computerized classification system of primary care: three years of experience]. Can Fam Physician 1995;41:1338-45. [PMID: 7580382 PMCID: PMC2146351] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA